News

PepGen Inc. Securities Fraud Class Action Alert for Investors

PepGen Inc. Securities Fraud Class Action Alert for Investors

Opportunity for Investors of PepGen Inc.

Investors who purchased shares of PepGen Inc. are invited to take part in a class action lawsuit concerning alleged securities fraud. The lawsuit has been initiated by The Schall Law Firm, a recognized leader in shareholder rights litigation.

Case Details and Significance

This class action lawsuit focuses on numerous claims against PepGen Inc., also known as "the Company", for purported violations of important securities regulations. The accusations specifically reference breaches of §10(b) and §20(a) within the Securities Exchange Act of 1934, along with Rule 10b-5 established by the U.S. Securities and Exchange Commission.

Timing and Class Period

Investors who bought the Company's securities between the dates of March 7, 2024, and March 3, 2025, are strongly encouraged to reach out to The Schall Law Firm before the deadline of August 8, 2025, for potential participation in the case.

Your Rights as a Shareholder

If you are a shareholder who may have suffered financial losses due to these allegations, it is vital to consider joining this class action to seek recovery. Interested parties can get in touch with The Schall Law Firm for a confidential discussion regarding their legal rights at no cost.

Allegations Against PepGen

The crux of the complaint alleges that PepGen misrepresented critical information to investors. Specifically, the safety and efficacy of PepGen's drug candidate, PGN-EDO51, were called into question. Reports suggest that the Company did not adequately provide data setting its CONNECT2 study as a safe and effective path to FDA approval, raising concerns about participant safety.

Possible Impact on Investors

According to the information disclosed, the outcome of PepGen's CONNECT2 study may lead to significant consequences, including halting the study altogether. Such developments could drastically impact the share price, compounding the losses incurred by investors during the stated class period.

Steps to Participate

Potential class members are welcome to join the lawsuit by contacting The Schall Law Firm. They are actively representing investors on this critical matter, making it essential for any injured parties to take swift action to protect their financial interests.

Contact Information

For further inquiries, investors may reach out to Brian Schall at The Schall Law Firm, located at 2049 Century Park East, Suite 2460. The firm's contact number is 310-301-3335. Additionally, they can visit the firm's website at www.schallfirm.com or send an email to bschall@schallfirm.com.

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit pertains to alleged securities fraud by PepGen Inc., related to false statements about its drug candidate's safety and efficacy.

Who can participate in the lawsuit?

Investors who purchased PepGen Inc. shares between March 7, 2024, and March 3, 2025, may join the class action.

How can I join the lawsuit?

Interested investors should contact The Schall Law Firm to discuss their eligibility and the process to participate.

What should I do if I suffered losses?

If you believe you suffered losses due to the alleged wrongful acts of PepGen, it is crucial to act immediately and consult an attorney.

What is the deadline for joining?

The deadline to join the lawsuit is August 8, 2025, for those who qualify.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 124

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Nomad Foods' Battle with Margins Amid Flat Volumes

Updated Category News Views 61

Subtle Winds of Change in Nomad Foods' Financials Ah, Nomad Foods—Europe's frozen food titan, trotting out its third quarter numbers like a well-rehearsed production line. You've got your slight revenue bump of 2.3% on reported streams, hitting €770 million. But dig a little deeper and you find organic revenue doing a waltz at 1.6% year-on-year, surprising no one...

Continue Reading
Tokenized Securities: Transfer Online's Next Frontier

Updated Category News Views 68

Transfer Online Teams Up with OnchainTA Hold onto your investment hats, folks—Transfer Online is linking arms with OnchainTA to step right into the future playground of tokenized securities. Now, what's that mean? Well, it's like jumping from sailing schooners to speedboats; we're entering a whole new era in capital markets. What's At Stake? The pair-up between these...

Continue Reading
Autohome's 2026 Q3 Results: Revenue Dips But Optimism Glows

Updated Category News Views 83

A Rollercoaster Quarter for Autohome Diving right into Autohome's latest financial results, and boy, it's not the cheeriest news we've heard. For Q3 2026, the famed online auto hub's net revenue is down to RMB1,315.0 million from RMB1,778.1 million a year prior. That's a hefty slide in any trader's book. More so, net income attributable to the company tumbled from...

Continue Reading
LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

Updated Category News Views 51

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Continue Reading
Everest Group Faces Shaky Ground in Securities Fraud Suit

Updated Category News Views 120

Investors Take Aim at Everest Group's Alleged Missteps Looks like Everest Group, Ltd. (NYSE: EG) has found itself knee-deep in legal quicksand. There's a class-action lawsuit afoot, spearheaded by the folks at Schall, Brown & Schwartz LLP. They're putting forward claims that Everest, a player in the securities exchange, was painting a misleading picture when it came to...

Continue Reading
Chord's Zenlytic Move: A Power Play in AI Expansion

Updated Category News Views 60

Chord's Bold Acquisition: Zenlytic Joins the Fold In a gutsy move that’s got folks buzzing, Chord has pulled Zenlytic into its orbit. Announced with a bang on November 3, 2026, this acquisition isn't just some flimsy, seasonal grab. They're doubling down on AI and doubling their revenue while they're at it. Now, brace yourselves: with giants like Verizon, J.Crew,...

Continue Reading
Samsung Biologics Hits 'Negligible' ESG Risk Milestone

Updated Category News Views 60

Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...

Continue Reading
BRIJ Medical Secures $5M: Paving Path for Product Launches

Updated Category News Views 64

In a world where medical advancements keep shifting gears, BRIJ Medical just pulled a fast one by closing a $5 million financing round—outpacing their original $3 million target. What drove this sudden increase? Well, it's simple. Their existing investors spotted an opportunity too ripe to pass up, proving yet again, money talks when confidence backs it up. Expanding...

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 64

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Growth Forecast for Global Gemstones Market

Updated Category News Views 273

Insights into the Growing Gemstones Market The gemstones market is witnessing a remarkable surge, fueled by changing consumer behaviors, advancements in technology, and increasing wealth in developing nations. Recent analyses reveal that the market was valued at USD 58,291.02 million in recent years and is expected to soar to USD 101.01 billion by 2032, achieving a...

Continue Reading
WTW Teams Up With The J. Morey Company for Enhanced Solutions

Updated Category News Views 116

WTW struck a deal back in 2024, teaming up with The J. Morey Company to beef up their brokerage offerings for businesses operating in North America and Asia. Traders were eyeing this move closely because WTW’s a big player in risk management solutions, and the partnership promised to tighten up their game significantly. The collaboration wasn’t just fluff—it aimed...

Continue Reading
Analyst Optimism Grows for Lightspeed Commerce's Revenue Surge

Updated Category News Views 72

Strategic Growth Plans for Lightspeed Commerce Recently, Lightspeed Commerce Inc, ticker LSPD, reported impressive quarterly results that exceeded market expectations. The company's growth can be primarily linked to effective transaction-based revenue generation, along with a rebound in subscription revenue, suggesting a strong business trajectory. Analyst Insights on...

Continue Reading
Chanson International's Strategic Focus on Growth Amid Challenges

Updated Category News Views 268

Chanson International Holding (NASDAQ: CHSN) reported its financial performance for the first half of the fiscal year, and let me tell ya, traders ain't thrilled. Total revenue hit $7.5 million, down from $8.8 million the year before—a clear sign that Chanson's trying to navigate some rough waters. Revenue Drops: What’s Behind the Numbers? The decline in revenue...

Continue Reading
Chicago Atlantic BDC, Inc. Engages at Emerging Growth Conference

Updated Category News Views 130

Chicago Atlantic BDC, Inc. Joins Emerging Growth Equity Conference NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (the Company) (NASDAQ: LIEN), a specialized finance entity determined to be regulated as a business development company, has officially announced its participation in the highly anticipated Noble Capital Markets Inc. 21st Annual...

Continue Reading